{
  "actions": [
    {
      "acted_at": "2015-02-12", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2015-02-13", 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr909-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "district": "26", 
      "name": "Burgess, Michael C.", 
      "sponsored_at": "2015-02-12", 
      "state": "TX", 
      "thomas_id": "01751", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Butterfield, G. K.", 
      "sponsored_at": "2015-02-12", 
      "state": "NC", 
      "thomas_id": "01761", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Cramer, Kevin", 
      "sponsored_at": "2016-02-01", 
      "state": "ND", 
      "thomas_id": "02144", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Fortenberry, Jeff", 
      "sponsored_at": "2015-03-16", 
      "state": "NE", 
      "thomas_id": "01793", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "9", 
      "name": "Griffith, H. Morgan", 
      "sponsored_at": "2015-02-12", 
      "state": "VA", 
      "thomas_id": "02070", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "22", 
      "name": "Hanna, Richard L.", 
      "sponsored_at": "2015-04-13", 
      "state": "NY", 
      "thomas_id": "02044", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "7", 
      "name": "Lance, Leonard", 
      "sponsored_at": "2015-02-12", 
      "state": "NJ", 
      "thomas_id": "01936", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "6", 
      "name": "Matsui, Doris O.", 
      "sponsored_at": "2015-02-12", 
      "state": "CA", 
      "thomas_id": "01814", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "52", 
      "name": "Peters, Scott H.", 
      "sponsored_at": "2015-05-05", 
      "state": "CA", 
      "thomas_id": "02113", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Walz, Timothy J.", 
      "sponsored_at": "2015-05-15", 
      "state": "MN", 
      "thomas_id": "01856", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2015-02-12", 
  "number": "909", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to expanding access for breakthrough drugs, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Andrea Sloan Compassionate Use Reform and Enhancement Act", 
  "sponsor": {
    "district": "10", 
    "name": "McCaul, Michael T.", 
    "state": "TX", 
    "thomas_id": "01804", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2015-02-12", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Administrative remedies", 
    "Advisory bodies", 
    "Congressional oversight", 
    "Consumer affairs", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug therapy", 
    "Executive agency funding and structure", 
    "Food and Drug Administration (FDA)", 
    "Government information and archives", 
    "Government studies and investigations", 
    "Health", 
    "Health care coverage and access"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2015-02-12", 
    "text": "Andrea Sloan Compassionate Use Reform and Enhancement Act or the Andrea Sloan CURE Act\n\nAmends the Federal Food, Drug, and Cosmetic Act to require the sponsor of an \u201cinvestigational drug\u201d (which is a drug that is designated as a breakthrough therapy, fast track product, infectious disease product, or drug for a rare disease or condition) to submit to the Food and Drug Administration (FDA) and make available to the public the sponsor's policy on requests for expanded access to the unapproved drug, including the minimum criteria for considering or approving requests and the time needed to make a decision.\n\nRequires an investigational drug sponsor to explain a denied request for expanded access to the person who made the request.\n\nDirects the Department of Health and Human Services to establish an Expanded Access Task Force. Requires the Task Force and the Government Accountability Office (GAO) to evaluate patient access to investigational drugs and make recommendations for improving access.\n\nDirects the FDA to finalize the draft guidance entitled \u201cExpanded Access to Investigational Drugs for Treatment Use--Qs & As,\u201d taking into account reports from the Task Force and GAO."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Andrea Sloan Compassionate Use Reform and Enhancement Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Andrea Sloan CURE Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to expanding access for breakthrough drugs, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2016-06-25T06:30:52-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d114:HR909:@@@L&summ2=m&"
}